Home / Recalls / West-Ward Columbus Inc / D-1863-2019

D-1863-2019 Class II Terminated

Recalled by West-Ward Columbus Inc — Columbus, OH

Recall Details

Product Type
Drugs
Report Date
September 25, 2019
Initiation Date
September 9, 2019
Termination Date
June 15, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
32,347 bottles

Product Description

Oxcarbazepine Oral Suspension, USP, 300 mg/5 mL, 250 mL per bottle, Rx Only, Distr. by: West-Ward Pharmaceuticals,Eatontown, NJ. NDC:0054-0199-59

Reason for Recall

Failed Impurities/Degradation Specificattion

Distribution Pattern

Nationwide USA and Puerto Rico

Code Information

Lot, expiry: Lots AA3957A, AA3958A, exp May 2020; Lot AA5164A, exp Sep 2020

Other recalls by West-Ward Columbus Inc

  • D-0183-2025 Class III — Methadone Hydrochloride Tablets, USP, 5mg, 10x10 Unit-Dose Tablets, Rx Only, Dis (December 19, 2024)
  • D-0066-2024 Class III — Methotrexate Tablets, USP, 2.5 mg, 10x10 Unit-Dose Tablets per carton, Rx only, (September 22, 2023)
  • D-1490-2020 Class III — Leucovorin Calcium Tablets USP, 10 mg, Rx only, 24 Tablets per bottle, Distr. by (July 22, 2020)
  • D-1282-2020 Class III — Ethacrynic Acid Tablets USP, 25 mg, 100 Tablets per Bottle, Rx only, Distr. by: (May 13, 2020)
  • D-1274-2020 Class II — Doxycycline Hyclate Tablets USP, 100 mg, packaged in a) 50-count bottle (NDC 014 (May 13, 2020)
  • D-1024-2018 Class II — Doxycycline Hyclate Tablets, USP, 100 mg*. 50-count bottle, Rx only. Manufacture (July 24, 2018)
  • D-1025-2018 Class II — Doxycycline Hyclate Tablets, USP, 100 mg*. 500-count bottle, Rx only. Manufactur (July 24, 2018)
  • D-0651-2017 Class III — Doxercalciferol Capsules 0.5mcg, 50 count bottles, Rx, only, Manufactured by Cip (April 4, 2017)
  • D-1441-2016 Class III — Oxycodone HCl, Oral Solution USP, 5 mg/5 mL, 15 mL bottles, Rx only, Boehringer (May 19, 2016)